Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 226

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Open access
Zhen, Shi-hui, Cheng, Ming, Tao, Yu-bo, Wang, Yi-fan, Juengpanich, Sarun, Jiang, Zhi-yu, Jiang, Yan-kai, Yan, Yu-yu, Lu, Wei, Lue, Jie-min, Qian, Jia-hong, Wu, Zhong-yu, Sun, Ji-hong, Lin, Hai, Cai, Xiu-jun · 2020 · Frontiers in Oncology

Abstract

Background: Early-stage diagnosis and treatment can improve survivals of liver cancer patients. Dynamic contrast-enhanced MRI provides the most comprehensive information for differential diagnosis of liver tumors. However, MRI diagnosis is affected by subjective experience, deep learning may supply a new diagnostic strategy. We used convolutional neural networks(CNNs) to develop a deep learning system(DLS) to classify liver tumors basing-on enhanced MR images, unenhanced MR images, and clinical data including text and laboratory test results.2 This is a provisional file, not the final typeset article Methods: Using data from 1210 patients with liver tumors(N = 31608 images), we trained CNNs to get seven-way classifiers, binary classifiers and three-way malignancy-classifiers (Model A-Model G). Models were validated in an external independent extended cohort of 201 patients( N = 6816 images). Area under receiver operating characteristic (ROC) curve (AUC) were compared across different models. We also compared the sensitivity and specificity of models with the performance of three experienced radiologists.Results: Deep learning achieves performance on par with three experienced radiologists on classifying liver tumors to seven categories. Using only un-enhanced images, CNN performs well to distinguish malignant from benign liver tumors (AUC of 0·946(95% CI 0·914-0·979) vs 0·951 (0·919-0·982), P=0.664). New CNN combining unenhanced images with clinical data greatly improved the performance of classifying malignancy as hepatocellular carcinoma(AUC of 0.985 (0.960-1.000)),metastatic tumors(0.998 (0.989-1.000)) and other primary malignancy(0.963 (0.896-1.000)), and the agreement with pathology was 91.9%.These models mined diagnostic information in unenhanced images and clinical data by deep-neural-network, which were different with previous method that utilized enhanced images. The sensitivity and specificity of almost every category in these models reached the same high level compared to three experienced radiologists.Trained with data in various acquisition condition, DLS that integrated these models could be served as an accurate and time-saving assisted-diagnostic strategy for liver tumors in clinical setting even in absence of contrast agents. DLS therefore has the potential to avoid contrast-related side effects and reduce economic costs associated with current standard MRI inspection practices for liver tumor patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fonc.2020.00680

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

Metadata

Authors
Zhen, S.-H., Cheng, M., Tao, Y.-B., Wang, Y.-F., Juengpanich, S., Jiang, Z.-Y., Jiang, Y.-K., Yan, Y.-Y., Lu, W., Lue, J.-M., Qian, J.-H., Wu, Z.-Y., Sun, J.-H., Lin, H., & Cai, X.-J.
Venue
Frontiers in Oncology
Published
2020-05-28
Volume
10
Pages
680-680
ISSN
2234-943X (ISSN-L)
OpenAlex
W3029385555
Cited by
226
References
13
FWCI
13.34
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.